J9245 Injection melpha hydroch not otherwise specified 50 milligrams
Also known as: melphalan, Alkeran
Intravenous injection of melphalan hydrochloride, not otherwise specified, an alkylating agent, dosed at 50 milligrams.
In Plain Language
DNA-damaging cancer drug; multiple myeloma treatment
Clinical Context
Used for multiple myeloma and other hematologic malignancies.
RVU Information
CPT J9245 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9245?
CPT J9245 (Injection melpha hydroch not otherwise specified 50 milligrams) is a J Codes (Drugs) code. Intravenous injection of melphalan hydrochloride, not otherwise specified, an alkylating agent, dosed at 50 milligrams.
How is J9245 administered?
CPT J9245 is administered by a healthcare provider, typically via injection or infusion. Used for multiple myeloma and other hematologic malignancies. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9245 used?
Used for multiple myeloma and other hematologic malignancies.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.